Form4insider filings, from the source

SEC Form 4 · accession 0001209191-18-028569

Karyopharm Therapeutics Inc. · KPTI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Sharon Shacham
Officer — President & CSO
Period of report
May 7, 2018
Accepted (ET)
May 8, 2018 · 4:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001503802

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 7, 2018M10,000$0.264A723,510D
Common StockF2May 7, 2018S10,000$16.7747D713,510D
Common Stockholding———512,143IBy Spouse
Common StockF3holding———47,309IBy GRAT
Common StockF4holding———47,309IBy Spouse's GRAT

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (right to buy)F5$0.264May 7, 2018M10,000D—Dec 15, 2021Common Stock10,0009,697D

Explanation of responses